--
Victoria
> From: anonymous@medispecialty.com (Belle)
> While the testing with Rezulin looked very good, it has been taken off
> of the market here because of the health problems that it created.
>
> At Wed, 13 Mar 2002, Victoria wrote:
> >
> > Troglitazone, an Insulin-Sensitizing Thiazolidinedione, Represses Combined
> >Stimulation by LH and Insulin of de Novo Androgen Biosynthesis by Thecal
Cells
> >in Vitro -- Journal of Clinical Endocrinology and Metabolism
> >
> ><a href=http://www.obgynlinx.com/thearts.cfm?artid=314104&specid=5>
> >http://www.obgynlinx.com/thearts.cfm?artid=314104&specid=5 </a>
> >
> >This ensemble of inhibitory actions on LH/insulin-stimulated steroidogenesis
> >offers a plausible mechanistic basis for at least part of the observed
clinical
> >efficacy of troglitazone in mitigating androgen excess in women with
polycystic
> >ovarian syndrome...
> >Victoria
> Belle
![[ PCOS Discussion Forums ]](../../images/pcos_at_obgyn.gif)